Anikó Somogyi

University Professor

Semmelweis University

Hungary

Research Interests

Explore related searches

Professors in Hungary Professors in Cancer Biology Cancer Biology professors in Hungary

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Anikó Somogyi is a University Professor at Semmelweis University in Hungary. Her research areas include the interplay between diabetes and cancer, particularly focusing on colorectal cancer and associated biomarkers. Recent publications explore topics such as the relationship between serum chromogranin levels and diabetes, as well as the impact of the PNPLA3 genotype on insulin resistance and lipid content. Her work aims to enhance understanding of the molecular mechanisms linking diabetes with cancer prognosis and treatment outcomes.

Articles (10)

Year:

2023

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Zsolt Lang

University of Veterinary Medicine

HUNGARY

View details

Zsolt Rónai

Semmelweis University

HUNGARY

View details

Gabor Firneisz

Aossociate Professor

Semmelweis University

HUNGARY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anikó Somogyi

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid content

Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?

Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis

Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment

Correlation between expression profiles of key signaling genes in colorectal cancer samples from type 2 diabetic and non-diabetic patients

Regular chromogranin A monitoring facilitated the early detection of a gastrointestinal neuroendocrine tumor in a patient with type 1 diabetes.

[Serum chromogranin A level in patients with type 2 diabetes]

Diabetes-specific modulation of peripheral blood gene expression signatures in colorectal cancer

Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes

Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin‐like cell hyperplasia and autoimmune gastritis

Collaborators (3)

Zsolt Lang

Zsolt Rónai

Gabor Firneisz

Make your next move.